Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer

G S Bhattacharyya; M Walia; M Nandi; A Murli; S Salim; S Rajpurohit; S Shinde; S Aggarwal; P M Parikh

doi:10.4103/sajc.sajc_126_18

Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer

South Asian J Cancer. 2018 Apr-Jun;7(2):156-158. doi: 10.4103/sajc.sajc_126_18.

Authors

G S Bhattacharyya¹, M Walia², M Nandi³, A Murli⁴, S Salim⁵, S Rajpurohit⁶, S Shinde⁷, S Aggarwal⁷, P M Parikh⁸

Affiliations

¹ Department of Medical Oncology, Fortis Hospital, Kolkata, West Bengal, India.
² Department of Medical Oncology, Max Hospital, New Delhi, India.
³ Department of Medical Oncology, Jaypee Hospital, Noida, Uttar Pradesh, India.
⁴ Department of Medical Oncology, Sarvodaya Hospital, Faridabad, Haryana, India.
⁵ Department of Oncology, Hakim Sanaullah Cancer Center, Sopore, Jammu and Kashmir, India.
⁶ Department of Medical Oncology, RGCI, New Delhi, India.
⁷ Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India.
⁸ Department of Oncology, Shalby Cancer and Research Institute, Mumbai, Maharashtra, India.

Abstract

This manuscript provides a practical and easy to use consensus recommendation to community oncologists on how to use neoadjuvant chemotherapy in triple negative breast cancer patients.

Keywords: Anthracycline; BCS; BRCA; SLNB; carboplatin; elderly; radiotherapy; taxane; tumor size.